Research Article

镰状细胞性贫血患者白细胞介素IL1ß/ IL18和炎症小体NLRP1 / NLRP3多态性的频率及其与严重度评分的关系

卷 19, 期 10, 2019

页: [776 - 783] 页: 8

弟呕挨: 10.2174/1566524019666190826143749

价格: $65

conference banner
摘要

背景:白介素IL1s / IL18和炎症小体NLRP1 / NLRP3多态性可以改变多种人类疾病的病程,既是传染性的,也是炎性的。这些蛋白的SNP与炎性体的建设性激活有关,并且IL-1β的过量产生会引起严重的自身炎症性疾病,如镰状细胞性贫血(SCA)。本研究旨在探讨亚马逊地区SCA患者白细胞介素IL1s / IL18与炎症小体NLRP1 / NLRP3多态性的关系及其与严重程度评分的关系。 方法:这项研究是在亚马逊河血友病医院(HEMOAM)进行的,其中21例被诊断为SCA(HbSS)的患者和50例健康捐赠者。通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)和实时PCR对白介素IL1s / IL18和炎性小体NLRP1 / NLRP3中的遗传多态性进行基因分型。进行了简单和多重逻辑回归分析,以研究多态性与SCA和严重评分之间的关联。 结果:C / C(IL18 -137G / C)和C / A(NLRP3,rs35829419)基因型似乎是SCA疾病的危险因素(IL18:G / G vs C / C OR = 103.500 [95%CI:8.32 -1287.79,p <0.00001]; IL18:G / G vs G / C OR = 7.360 [95%CI:0.85-63.48,p = 0.040]; IL18:G / G vs CC + CG OR = 14.481 [95%CI :1.79-117.32,p = 0.002; NLRP3:C / C与C / A:OR = 10.967 [95%CI:2.41-49.89,p = 0.0004])。此外,只有等位基因C(IL18 -137G / C)和A(NLRP3)似乎是SCA疾病的危险因素(IL18:G vs C OR = 6.366 [95%CI:2.73-14.86,p <0.00001]; NLRP3 :C vs A OR = 8.383 [95%CI:2.03-34.62,p = 0.005]。在基因型和等位基因与严重性评分之间未发现关联。 结论:描述了IL18(rs16944)和NLRP3(rs35829419)多态性与镰状细胞性贫血相关的证据。我们的结果表明,已评估基因型的个体与SCA疾病相关,即使它不影响严重评分。

关键词: SCA,多态性,促炎细胞因子,炎性体,白介素。

[1]
Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest 2007; 117(4): 850-8.
[http://dx.doi.org/10.1172/JCI30920] [PMID: 17404610]
[2]
Solomou E, Kraniotis P, Kourakli A, Petsas T. Extent of silent cerebral infarcts in adult sickle-cell disease patients on magnetic resonance imaging: is there a correlation with the clinical severity of disease? Hematol Rep 2013; 5(1): 8-12.
[http://dx.doi.org/10.4081/hr.2013.e3] [PMID: 23888239]
[3]
van den Tweel XW, van der Lee JH, Heijboer H, Peters M, Fijnvandraat K. Development and validation of a pediatric severity index for sickle cell patients. Am J Hematol 2010; 85(10): 746-51.
[http://dx.doi.org/10.1002/ajh.21846] [PMID: 20806231]
[4]
Pearson SR, Alkon A, Treadwell M, Wolff B, Quirolo K, Boyce WT. Autonomic reactivity and clinical severity in children with sickle cell disease. Clin Auton Res 2005; 15(6): 400-7.
[http://dx.doi.org/10.1007/s10286-005-0300-9] [PMID: 16362543]
[5]
Dutra FF, Bozza MT. Heme on innate immunity and inflammation. Front Pharmacol 2014; 5: 115.
[http://dx.doi.org/10.3389/fphar.2014.00115] [PMID: 24904418]
[6]
Bayley J-P, Ottenhoff THM, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun 2004; 5(5): 315-29.
[http://dx.doi.org/10.1038/sj.gene.6364055] [PMID: 14973548]
[7]
Sortica VA, Cunha MG, Ohnishi MD, et al. IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil. Malar J 2012; 11: 409.
[http://dx.doi.org/10.1186/1475-2875-11-409] [PMID: 23217179]
[8]
Kumar D, Tiwary P, Chakravarty J, Sundar S. Association of interleukin-18 gene polymorphism with susceptibility to visceral leishmaniasis in endemic area of Bihar, an Indian Population Sci World J 2014; 2014.
[http://dx.doi.org/10.1155/2014/852104]
[9]
Folwaczny M, Glas J, Török H-P, et al. Polymorphisms of the interleukin-18 gene in periodontitis patients. J Clin Periodontol 2005; 32(5): 530-4.
[http://dx.doi.org/10.1111/j.1600-051X.2005.00711.x] [PMID: 15842270]
[10]
Sebastiani P, Nolan VG, Baldwin CT, et al. A network model to predict the risk of death in sickle cell disease. Blood 2007; 110(7): 2727-35.
[http://dx.doi.org/10.1182/blood-2007-04-084921] [PMID: 17600133]
[11]
Ferreira S da C, Chachá SGF, Souza FF, et al. IL-18, TNF, and IFN-γ alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury. J Med Virol 2015; 87(10): 1689-96.
[http://dx.doi.org/10.1002/jmv.24225] [PMID: 25952099]
[12]
El-Omar EM, Carrington M, Chow W-H, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404(6776): 398-402.
[http://dx.doi.org/10.1038/35006081] [PMID: 10746728]
[13]
Bhat IA, Naykoo NA, Qasim I, et al. Association of interleukin 1 beta (IL-1β) polymorphism with mRNA expression and risk of non small cell lung cancer. Meta Gene 2014; 2: 123-33.
[http://dx.doi.org/10.1016/j.mgene.2013.12.002] [PMID: 25606396]
[14]
Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007; 356(12): 1216-25.
[http://dx.doi.org/10.1056/NEJMoa061592] [PMID: 17377159]
[15]
Davis BK, Wen H, Ting JP-Y. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011; 29: 707-35.
[http://dx.doi.org/10.1146/annurev-immunol-031210-101405] [PMID: 21219188]
[16]
Belcher JD, Chen C, Nguyen J, et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 2014; 123(3): 377-90.
[http://dx.doi.org/10.1182/blood-2013-04-495887] [PMID: 24277079]
[17]
Verma D, Lerm M, Blomgran Julinder R, Eriksson P, Söderkvist P, Särndahl E. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases? Arthritis Rheum 2008; 58(3): 888-94.
[http://dx.doi.org/10.1002/art.23286] [PMID: 18311798]
[18]
Chi DZ, Chen J, Huang DP. Influence of interleukin-1β and interleukin-6 gene polymorphisms on the development of acute pancreatitis. Genet Mol Res 2015; 14(1): 975-80.
[http://dx.doi.org/10.4238/2015.February.3.5] [PMID: 25730036]
[19]
Santos KN, Almeida MK, Fecury AA, Costa CA, Martins LC. Analysis of Polymorphisms in the Interleukin 18 Gene Promotor (-137 G/C and -607 C/A) in Patients Infected with Hepatitis C Virus from the Brazilian Amazon. Arq Gastroenterol 2015; 52(3): 222-7.
[http://dx.doi.org/10.1590/S0004-28032015000300013] [PMID: 26486291]
[20]
Karra VK, Gumma PK, Chowdhury SJ, et al. IL-18 polymorphisms in hepatitis B virus related liver disease. Cytokine 2015; 73(2): 277-82.
[http://dx.doi.org/10.1016/j.cyto.2015.02.015] [PMID: 25802197]
[21]
de Zoete MR, Palm NW, Zhu S, Flavell RA. Inflammasomes. Cold Spring Harb Perspect Biol 2014; 6(12): a016287-7.
[http://dx.doi.org/10.1101/cshperspect.a016287] [PMID: 25324215]
[22]
Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, et al. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proc Natl Acad Sci U S A National Academy of Sciences 2013; 110: 2952-6.
[23]
Pontillo A, Oshiro TM, Girardelli M, Kamada AJ, Crovella S, Duarte AJS. Polymorphisms in inflammasome’ genes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 2012; 59(2): 121-5.
[http://dx.doi.org/10.1097/QAI.0b013e3182392ebe] [PMID: 22227487]
[24]
Hitomi Y, Ebisawa M, Tomikawa M, et al. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J Allergy Clin Immunol 2009; 124(4): 779-85.e6.
[http://dx.doi.org/10.1016/j.jaci.2009.07.044] [PMID: 19767079]
[25]
Pontillo A, Brandão LA, Guimarães RL, Segat L, Athanasakis E, Crovella SA. 3'UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 2010; 54(3): 236-40.
[http://dx.doi.org/10.1097/QAI.0b013e3181dd17d4] [PMID: 20502346]
[26]
Verma D, Särndahl E, Andersson H, et al. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1β and IL-18 production. PLoS One 2012; 7(4)e34977
[http://dx.doi.org/10.1371/journal.pone.0034977] [PMID: 22529966]
[27]
Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29(3): 301-5.
[http://dx.doi.org/10.1038/ng756] [PMID: 11687797]
[28]
Zhang Q, Fan HW, Zhang JZ, Wang YM, Xing HJ. NLRP3 rs35829419 polymorphism is associated with increased susceptibility to multiple diseases in humans. Genet Mol Res 2015; 14(4): 13968-80.
[http://dx.doi.org/10.4238/2015.October.29.17] [PMID: 26535712]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy